Aryx Financial Statements From 2010 to 2026
| ARYX Stock | USD 0.0005 0.00 0.00% |
Check Aryx Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aryx Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Aryx financial statements analysis is a perfect complement when working with Aryx Therapeutics Valuation or Volatility modules.
Aryx |
Aryx Therapeutics I Company Number Of Shares Shorted Analysis
Aryx Therapeutics' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Aryx Therapeutics Number Of Shares Shorted | 89.05 K |
Most of Aryx Therapeutics' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aryx Therapeutics I is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Aryx Therapeutics I has 89.05 K of outstending shares currently sold short by investors. This is 97.22% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is 98.11% higher than that of the company.
Aryx Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aryx Therapeutics's current stock value. Our valuation model uses many indicators to compare Aryx Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aryx Therapeutics competition to find correlations between indicators driving Aryx Therapeutics's intrinsic value. More Info.Aryx Therapeutics I is rated fourth in return on asset category among its peers. It is rated second in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aryx Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aryx Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Aryx Therapeutics Financial Statements
Aryx Therapeutics investors use historical fundamental indicators, such as Aryx Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Aryx Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aryx Pink Sheet Analysis
When running Aryx Therapeutics' price analysis, check to measure Aryx Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aryx Therapeutics is operating at the current time. Most of Aryx Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aryx Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aryx Therapeutics' price. Additionally, you may evaluate how the addition of Aryx Therapeutics to your portfolios can decrease your overall portfolio volatility.